Healthcare & Life Sciences
Exai Bio
United Statesexai.bio
Exai Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
activeseries-a
series-a
Stage
1
Investors
About Exai Bio
Exai Bio is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Exai Bio is a next-generation liquid biopsy company that utilizes RNA biomarkers and artificial intelligence to deliver clinical insights into cancer biology, enabling early and accurate cancer detection through non-invasive blood tests.
Explore Exai Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.